List of works - Stephen E Langabeer

" V617F Mutation in Cervical Cancer Related to HPV & STIs" - Letter

scientific article published on 30 March 2019

A doctor(s) dilemma: ETV6-ABL1 positive acute lymphoblastic leukaemia

scientific article published on 7 July 2010

A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.

scientific article

Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

scientific article published on 21 January 2016

Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.

scientific article published on 16 September 2011

Adenomatoid tumor of the testis in a patient on imatinib therapy for chronic myeloid leukemia

scientific article published on 01 July 2006

An acquired NRAS mutation contributes to neutrophilic progression in a patient with primary myelofibrosis

scientific article published on 29 September 2017

Aquagenic pruritus and the JAK2 V617F mutation

scientific article published on 21 December 2018

BCR-ABL1 kinase domain mutation analysis in an Irish cohort of chronic myeloid leukemia patients

scientific article published on 05 January 2013

CALR mutation profile in Irish patients with myeloproliferative neoplasms.

scientific article published on 23 June 2016

Capricious CALR mutated clones in myeloproliferative neoplasms

scientific article published on 7 January 2016

Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring

scientific article

Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring.

scientific article published on 16 October 2017

Comment on: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia.

scientific article

Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha.

scientific article published on 30 May 2010

Considerations and recommendations for a new molecular diagnostic algorithm for the myeloproliferative neoplasms

scientific article published on 26 September 2014

Double-mutant myeloproliferative neoplasms

scientific article published on 29 August 2018

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation

scientific article published on 9 August 2015

Getting Hot Under the CALR: What Drives Pediatric Myeloproliferative Neoplasms?

scientific article published on 13 August 2015

Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy

scientific article published on 21 August 2019

Identification of MPL W515L/K mutations in patients with primary myelofibrosis and essential thrombocythaemia by allele-specific polymerase chain reaction.

scientific article

Incidence and prognostic significance of C-MPL expression in acute myeloid leukemia

scientific article published on 01 September 2003

Incidence of CALR mutations in patients with splanchnic vein thrombosis

scientific article published on 16 September 2014

Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.

scientific article published on 9 January 2012

Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukaemia. MRC Adult Leukaemia Working Party

scientific article published on 01 March 1997

Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia

scientific article

Is the BCR-ABL1 transcript type in chronic myeloid leukaemia relevant? ⬇️

scientific article published on February 21, 2013

JAK2 mutations to the fore in hereditary thrombocythemia.

scientific article published on 30 October 2014

Lack of National Consensus for the Molecular Investigation of Myeloproliferative Neoplasms.

scientific article

Lack of myeloproliferative neoplasm-associated CALR mutations in acute promyelocytic leukemia

scientific article published on 07 October 2014

Late Emergence of an Imatinib-Resistant ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia

scientific article

Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3 BCR-ABL1 Fusion

scientific article published on 27 June 2019

Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia.

scientific article

Molecular diagnostics of myeloproliferative neoplasms.

scientific article published on 07 May 2015

Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations.

scientific article

Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

scientific article published on 01 September 2011

Molecular response to imatinib in KIT F522C-mutated systemic mastocytosis

scientific article published on 24 December 2018

Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion

scientific article

Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches

scientific article

Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7.

scientific article published in May 2002

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis.

scientific article

Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts

scientific article published on 25 March 2010

No indication for CALR mutation analysis in Irish patients presenting with deep vein thrombosis or pulmonary embolism

scientific article published on 11 April 2019

Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia

scientific article published on 23 March 2020

Prefibrotic Myelofibrosis Presenting with Multiple Cerebral Embolic Infarcts and the Rare MPL W515S Mutation

scientific article published on 19 June 2020

Prevalence of the JAK2 V617F and MPL mutations in stroke, abdominal and peripheral venous thrombosis

scientific article published on 13 October 2010

Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia.

scientific article published on 9 May 2018

Real-world experience of <i>BRAF</i> V600E mutation testing in hairy cell leukaemia

scientific article published on 28 December 2020

Reduction in molecular diagnostics of myeloproliferative neoplasms during the COVID-19 pandemic

scientific article published on 08 July 2020

Reflective molecular testing for myeloproliferative neoplasms in patients with elevated serum vitamin B12

scientific article published on 30 July 2018

Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia.

scientific article published in January 2016

Repeat JAK2 V617F testing in patients with suspected essential thrombocythaemia

scientific article published on 09 July 2020

Screening for mutations of Bcl10 in leukaemia

scientific article published on 01 June 2000

Sorafenib for relapsed FLT3-ITD-positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis

scientific article published on 19 October 2019

Standardized Molecular Monitoring for Variant BCR-ABL1 Transcripts in Chronic Myeloid Leukemia.

scientific article

Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.

scientific article published on 12 February 2010

Sustained molecular response with nilotinib in imatinib-intolerant chronic myeloid leukaemia with an e19a2 BCR-ABL1 fusion

scientific article published on 23 June 2016

Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis

scientific article published on 31 July 2017

Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia

scientific article published on 3 November 2015

The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis

scientific article

The JAK2 V617F Mutation in Plasma Cell Neoplasms with Co-existing Erythrocytosis

scientific article published on December 2015

The JAK2 V617F mutation in breast cancer?

The e1a3 BCR-ABL1 fusion transcript in philadelphia chromosome-positive acute lymphoblastic leukemia

scientific article published on September 2015

The impact of sample processing delay on deep molecular responses in chronic myeloid leukemia

scientific article published on 06 June 2018

The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics

scientific article published on 01 December 2012

To screen for CALR mutations in patients with splanchnic vein thrombosis?

scientific article published in January 2015

Transient JAK2 V617F mutation in an aplastic anaemia patient with a paroxysmal nocturnal haemoglobinuria clone

scientific article published on 30 January 2013

Up-front Screening for the JAK2 V617F Mutation in Patients Presenting with Thrombosis other than Splanchnic Vein Thrombosis.

scientific article published in January 2015

c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia

scientific article published on 01 June 1999

List of works by Stephen E Langabeer

" V617F Mutation in Cervical Cancer Related to HPV & STIs" - Letter

A doctor(s) dilemma: ETV6-ABL1 positive acute lymphoblastic leukaemia

A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.

Adenomatoid tumor of the testis in a patient on imatinib therapy for chronic myeloid leukemia

An acquired NRAS mutation contributes to neutrophilic progression in a patient with primary myelofibrosis

Aquagenic pruritus and the JAK2 V617F mutation

BCR-ABL1 kinase domain mutation analysis in an Irish cohort of chronic myeloid leukemia patients

CALR mutation profile in Irish patients with myeloproliferative neoplasms.

Capricious CALR mutated clones in myeloproliferative neoplasms

Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring

Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring.

Comment on: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia.

Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha.

Considerations and recommendations for a new molecular diagnostic algorithm for the myeloproliferative neoplasms

Double-mutant myeloproliferative neoplasms

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation

Getting Hot Under the CALR: What Drives Pediatric Myeloproliferative Neoplasms?

Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy

Identification of MPL W515L/K mutations in patients with primary myelofibrosis and essential thrombocythaemia by allele-specific polymerase chain reaction.

Incidence and prognostic significance of C-MPL expression in acute myeloid leukemia

Incidence of CALR mutations in patients with splanchnic vein thrombosis

Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.

Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukaemia. MRC Adult Leukaemia Working Party

Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia

Is the BCR-ABL1 transcript type in chronic myeloid leukaemia relevant? ⬇️

JAK2 mutations to the fore in hereditary thrombocythemia.

Lack of National Consensus for the Molecular Investigation of Myeloproliferative Neoplasms.

Lack of myeloproliferative neoplasm-associated CALR mutations in acute promyelocytic leukemia

Late Emergence of an Imatinib-Resistant ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia

Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3 BCR-ABL1 Fusion

Molecular Profiling: A Case of ZBTB16-RARA Acute Promyelocytic Leukemia.

Molecular diagnostics of myeloproliferative neoplasms.

Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations.

Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

Molecular response to imatinib in KIT F522C-mutated systemic mastocytosis

Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion

Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches

Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7.

Myelodysplastic Syndrome/Acute Myeloid Leukemia Arising in Idiopathic Erythrocytosis.

Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts

No indication for CALR mutation analysis in Irish patients presenting with deep vein thrombosis or pulmonary embolism

Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia

Prefibrotic Myelofibrosis Presenting with Multiple Cerebral Embolic Infarcts and the Rare MPL W515S Mutation

Prevalence of the JAK2 V617F and MPL mutations in stroke, abdominal and peripheral venous thrombosis

Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia.

Real-world experience of <i>BRAF</i> V600E mutation testing in hairy cell leukaemia

Reduction in molecular diagnostics of myeloproliferative neoplasms during the COVID-19 pandemic

Reflective molecular testing for myeloproliferative neoplasms in patients with elevated serum vitamin B12

Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia.

Repeat JAK2 V617F testing in patients with suspected essential thrombocythaemia

Screening for mutations of Bcl10 in leukaemia

Sorafenib for relapsed FLT3-ITD-positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis

Standardized Molecular Monitoring for Variant BCR-ABL1 Transcripts in Chronic Myeloid Leukemia.

Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.

Sustained molecular response with nilotinib in imatinib-intolerant chronic myeloid leukaemia with an e19a2 BCR-ABL1 fusion

Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis

Targeted next-generation sequencing of familial platelet disorder with predisposition to acute myeloid leukaemia

The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis

The JAK2 V617F Mutation in Plasma Cell Neoplasms with Co-existing Erythrocytosis

The JAK2 V617F mutation in breast cancer?

The e1a3 BCR-ABL1 fusion transcript in philadelphia chromosome-positive acute lymphoblastic leukemia

The impact of sample processing delay on deep molecular responses in chronic myeloid leukemia

The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics

To screen for CALR mutations in patients with splanchnic vein thrombosis?

Transient JAK2 V617F mutation in an aplastic anaemia patient with a paroxysmal nocturnal haemoglobinuria clone

Up-front Screening for the JAK2 V617F Mutation in Patients Presenting with Thrombosis other than Splanchnic Vein Thrombosis.

c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia